New York State Common Retirement Fund cut its holdings in shares of Boston Scientific Corporation (NYSE:BSX) by 1.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,986,672 shares of the medical equipment provider’s stock after selling 38,241 shares during the period. New York State Common Retirement Fund owned 0.29% of Boston Scientific Corporation worth $110,511,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in BSX. Bronfman E.L. Rothschild L.P. grew its position in shares of Boston Scientific Corporation by 7.2% during the first quarter. Bronfman E.L. Rothschild L.P. now owns 5,041 shares of the medical equipment provider’s stock worth $125,000 after acquiring an additional 338 shares during the last quarter. Guardian Life Insurance Co. of America grew its position in shares of Boston Scientific Corporation by 0.9% during the first quarter. Guardian Life Insurance Co. of America now owns 5,266 shares of the medical equipment provider’s stock worth $131,000 after acquiring an additional 49 shares during the last quarter. Acrospire Investment Management LLC grew its position in shares of Boston Scientific Corporation by 157.3% during the second quarter. Acrospire Investment Management LLC now owns 5,071 shares of the medical equipment provider’s stock worth $141,000 after acquiring an additional 3,100 shares during the last quarter. Peddock Capital Advisors LLC purchased a new position in shares of Boston Scientific Corporation during the second quarter worth approximately $201,000. Finally, Commerce Bank purchased a new position in shares of Boston Scientific Corporation during the first quarter worth approximately $207,000. Institutional investors and hedge funds own 90.44% of the company’s stock.

Several equities research analysts recently weighed in on the company. BidaskClub downgraded Boston Scientific Corporation from a “hold” rating to a “sell” rating in a report on Saturday, August 26th. Stifel Nicolaus increased their price target on Boston Scientific Corporation from $30.00 to $32.00 and gave the stock a “hold” rating in a report on Wednesday, June 28th. Oppenheimer Holdings, Inc. set a $29.00 price target on Boston Scientific Corporation and gave the stock a “hold” rating in a report on Friday, July 28th. Royal Bank Of Canada reaffirmed a “buy” rating and set a $31.00 price target on shares of Boston Scientific Corporation in a report on Friday, September 1st. Finally, Zacks Investment Research downgraded Boston Scientific Corporation from a “hold” rating to a “sell” rating in a report on Tuesday, July 11th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $29.88.

COPYRIGHT VIOLATION WARNING: “New York State Common Retirement Fund Lowers Stake in Boston Scientific Corporation (BSX)” was originally published by Daily Political and is owned by of Daily Political. If you are viewing this story on another site, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this story can be accessed at https://www.dailypolitical.com/2017/09/18/new-york-state-common-retirement-fund-lowers-stake-in-boston-scientific-corporation-bsx.html.

In other news, EVP Michael P. Phalen sold 15,500 shares of the company’s stock in a transaction on Thursday, June 29th. The stock was sold at an average price of $28.02, for a total transaction of $434,310.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Timothy A. Pratt sold 10,000 shares of the company’s stock in a transaction on Monday, July 3rd. The shares were sold at an average price of $27.87, for a total value of $278,700.00. Following the sale, the executive vice president now directly owns 205,846 shares of the company’s stock, valued at $5,736,928.02. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 275,257 shares of company stock valued at $7,512,394. 0.74% of the stock is currently owned by company insiders.

Boston Scientific Corporation (NYSE BSX) traded down 0.21% on Monday, hitting $28.87. The stock had a trading volume of 1,718,306 shares. The stock has a 50-day moving average of $27.28 and a 200-day moving average of $26.52. Boston Scientific Corporation has a one year low of $19.67 and a one year high of $29.40. The company has a market cap of $39.61 billion, a PE ratio of 51.65 and a beta of 1.09.

Boston Scientific Corporation (NYSE:BSX) last announced its quarterly earnings data on Thursday, July 27th. The medical equipment provider reported $0.32 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.31 by $0.01. Boston Scientific Corporation had a return on equity of 23.62% and a net margin of 9.04%. The business had revenue of $2.26 billion during the quarter, compared to analyst estimates of $2.21 billion. During the same quarter in the prior year, the firm posted $0.27 earnings per share. The company’s revenue was up 6.2% on a year-over-year basis. Equities analysts expect that Boston Scientific Corporation will post $1.26 earnings per share for the current fiscal year.

About Boston Scientific Corporation

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology.

Want to see what other hedge funds are holding BSX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Boston Scientific Corporation (NYSE:BSX).

Institutional Ownership by Quarter for Boston Scientific Corporation (NYSE:BSX)

Receive News & Ratings for Boston Scientific Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boston Scientific Corporation and related companies with MarketBeat.com's FREE daily email newsletter.